NewsRx

Search our medical news database

Allergies

WellPoint NextRx Pilots Over the Counter Medication Program with Blue Cross & Blue Shield of Rhode Island

Published in Health Insurance Week, April 27th, 2008

WellPoint NextRx, the nation's largest health plan-owned pharmacy benefit manager (PBM), announced the results of a recently completed pilot program launched for its unaffiliated plan Blue Cross & Blue Shield of Rhode Island (BCBSRI) for generic over the counter medications. Under the OTC Options Program, BCBSRI members had the option of receiving over the counter medications -- such as the allergy drug Loratadine -- at no charge as an alternative to a prescription medication for a period of one year.

The program took the pinch out of allergy season by helping offset the out-of-pocket costs for members who typically fill a prescription strength medication such as...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook